Belvedere Trading’s Kodiak Sciences KOD Stock Holding History

Belvedere Trading’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$5.59K	–	880
2025 Q4	$5.59K	Buy	+200	New	+$4.1K	﹤0.01%	786

Other funds holding KOD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Belvedere Trading's KOD Position: Q1 2026 in Review

Belvedere Trading sold out of Kodiak Sciences (KOD) in Q1 2026, closing a stake of 8,037 shares — an estimated $225K sold.

Belvedere Trading first reported a position in KOD in Q2 2023 and held it in 2 quarters. The position peaked at $225K in Q4 2025. 188 funds tracked by Wall St. Rank hold KOD as of Q1 2026.

Belvedere Trading reported no remaining Kodiak Sciences position as of Q1 2026 after selling out during the quarter.
Belvedere Trading sold 8,037 Kodiak Sciences shares in Q1 2026, an estimated $225K.
Belvedere Trading first reported a position in Kodiak Sciences in Q2 2023 and held it in 2 quarters.
Belvedere Trading's Kodiak Sciences position peaked at $225K in Q4 2025.
188 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2026.

Based on Belvedere Trading's 13F filing for Q1 2026, filed 12 May 2026.